Table 3: Comparison of the expression of four antibodies in polyp group and control group at different endometrial stages.
|
|
Polyps group |
Control group |
||
|
Proliferative phase (n = 28) |
Secretory phase (n = 24) |
Proliferative phase (n = 21) |
Secretory phase (n = 12) |
|
|
InR |
2.18 ± 0.55 |
2.38 ± 0.58 |
2.14 ± 0.57 |
2.17 ± 0.58 |
|
IGF-1R IRS-1 |
2.29 ± 0.54 2.14 ± 0.45 |
2.21 ± 0.51 2.38 ± 0.58 |
2.05 ± 0.50 2.10 ± 0.54 |
2.00 ± 0.60 2.00 ± 0.74 |
|
IRS-2 |
2.25 ± 0.52 |
2.21 ± 0.721 |
2.10 ± 0.70 |
2.17 ± 0.58 |